P2RY11
MOLECULAR TARGETpurinergic receptor P2Y11
P2RY11 (purinergic receptor P2Y11) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting P2RY11
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Adenosine Triphosphate | 1.95 | 6 |
| 2 | Suramin | 1.39 | 3 |
| 3 | Adenosine Diphosphate Adenosine 5'-(trihydrogen diphosphate). | 1.10 | 2 |
| 4 | NAD | 0.69 | 1 |
| 5 | NAD | 0.69 | 1 |
| 6 | NAD | 0.69 | 1 |
| 7 | Uridine Triphosphate Uridine 5'-(tetrahydrogen triphosphate). | 0.69 | 1 |
About P2RY11 as a Drug Target
P2RY11 (purinergic receptor P2Y11) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented P2RY11 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
P2RY11 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.